Aspen Aerogels reports Q1 2026 loss of $23.7M amid East Providence plant restart and market challenges

Aspen Aerogels reported a net loss of $23.7 million in Q1 2026, down significantly from a $301.2 million loss the previous year, impacted by reduced demand and a manufacturing facility explosion in East Providence. The company expects a staged restart of the damaged facility starting in May and is leveraging external manufacturing to meet demand. Despite revenue dropping to $37.9 million from $78.7 million year-over-year, Aspen secured a new subsea pipeline project and ended the quarter with $175.6 million in cash. The company forecasts improved revenue and profitability in Q2 2026 as it navigates operational recovery and market conditions.